Your session is about to expire
← Back to Search
Double Voiding for Urinary Tract Infection Prevention Post-Kidney Transplant
N/A
Recruiting
Led By Muthukumar Thangamani, M.D.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first 3 months of transplantation
Awards & highlights
Study Summary
This trial will assess if "double voiding" reduces UTI risk for kidney transplant recipients, lowering the risk of infection and rejection of the organ.
Who is the study for?
This trial is for adult kidney transplant recipients who are being routinely followed at the NYP-WCM Transplant Clinic. It's not for those discharged with an indwelling catheter (Foley) after their transplant.Check my eligibility
What is being tested?
The study compares 'double voiding'—a technique to empty the bladder more completely—with regular voiding to see if it reduces urinary tract infections in new kidney transplant patients.See study design
What are the potential side effects?
There are no direct side effects from participating in this trial as it involves non-invasive techniques of urination, but UTIs themselves can cause discomfort, fever, and may require antibiotics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ first 3 months of transplantation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first 3 months of transplantation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of UTI's
Secondary outcome measures
Bacterial colony count of each positive urine culture
Number of UTI episodes
Number of hospital admissions
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Double VoidingExperimental Treatment1 Intervention
The participant will be instructed to void twice.
Group II: Regular VoidingActive Control1 Intervention
The participant will be instructed to void normally.
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,055 Previous Clinical Trials
1,315,857 Total Patients Enrolled
Muthukumar Thangamani, M.D.Principal InvestigatorWeill Medical College of Cornell University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You recently had a kidney transplant and still have a catheter in place.All adults who have had a kidney transplant and are regularly seen at the New York Presbyterian - Weill Cornell Medicine Transplant Clinic.
Research Study Groups:
This trial has the following groups:- Group 1: Double Voiding
- Group 2: Regular Voiding
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the recruitment phase for this experiment ongoing?
"Clinicaltrials.gov data indicates that this trial is not presently enrolling participants, despite its initial posting on February 1st 2023 and last update two days later. Fortunately, there are 800 other trials currently searching for volunteers to take part in the study."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger